US OptionsDetailed Quotes
NMRA250117C2000
- 0.59
- +0.19+47.50%
15min DelayClose Jan 6 16:00 ET
0.60High0.35Low
0.35Open0.40Pre Close196 Volume1.05K Open Interest2.00Strike Price9.82KTurnover238.09%IV4.44%PremiumJan 17, 2025Expiry Date0.48Intrinsic Value100Multiplier10DDays to Expiry0.11Extrinsic Value100Contract SizeAmericanOptions Type0.7693Delta0.3026Gamma3.82Leverage Ratio-0.0149Theta0.0004Rho2.93Eff Leverage0.0013Vega
Neumora Therapeutics Stock Discussion
The average price target for Neumora Therapeutics, Inc. is $24.17. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $30.00 ,the lowest forecast is $15.00.
H.C. Wainwright reaffirmed its Buy rating and a price target of $30.00 for Neumora Therapeutics (NASDAQ:NMRA) stock.
——-
On Friday, Mizuho (NYSE:MFG) Securities reiterated its Outperform rating on Neumora Therapeutics (NASDAQ:NMRA) with a steady price target of $20.00, despite the company's recent setback with its lead drug candidate, navacaprant.
———-
jp morgan target price 15
Many antidepressants have had at least one Phase 3 failure before winning approval
No comment yet